The rise of Viagra initially drove a surge for pharma, nevertheless recent shifts present a complicated outlook for investors. Generic versions are eating into revenue, and continued litigation add further risk to the https://caoimheftoj363732.blogdal.com/41599349/viagra-and-pharma-a-risky-investment